Phathom Pharmaceuticals Inc (PHAT)
4.84 +0.43 (+9.75%) 03/17/25 [NASDAQ]
4.50 x 100 5.42 x 100
Realtime by (Cboe BZX)
4.50 x 100 5.42 x 100
Realtime - - (-) -
for Mon, Mar 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 35,659 | 31,701 | 30,077 | 46,642 | 42,529 |
| Operating Income | -35,659 | -31,701 | -30,077 | -46,642 | -42,529 |
| Interest Expense | 10,107 | 9,615 | 9,217 | 9,602 | 9,277 |
| Other Income | 2,523 | 351 | 1,480 | 1,197 | 715 |
| Pre-tax Income | -43,243 | -40,965 | -37,814 | -55,047 | -51,091 |
| Net Income Continuous | -43,243 | -40,965 | -37,814 | -55,047 | -51,091 |
| Net Income | $-43,243 | $-40,965 | $-37,814 | $-55,047 | $-51,091 |
| EPS Basic Total Ops | -0.76 | -0.84 | -0.89 | -1.33 | -1.32 |
| EPS Basic Continuous Ops | -0.76 | -0.84 | -0.89 | -1.34 | -1.32 |
| EPS Diluted Total Ops | -0.76 | -0.84 | -0.89 | -1.33 | -1.32 |
| EPS Diluted Continuous Ops | -0.76 | -0.84 | -0.89 | -1.34 | -1.32 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -0.84 | -0.89 | N/A | N/A |
| EBITDA(a) | $-34,996 | $-31,305 | $-29,435 | $-45,977 | $-41,790 |